Overview

Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients

Status:
COMPLETED
Trial end date:
2022-11-28
Target enrollment:
Participant gender:
Summary
This study is planned to Evaluate the Efficacy and Safety of test drug (AJU-S56) compared to control drug(vehicle) in Patients with Dry Eye Disease.
Phase:
PHASE2
Details
Lead Sponsor:
AJU Pharm Co., Ltd.
Collaborator:
GL Pharm Tech Corporation